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Antioxidative activity and inhibition of key enzymes 
linked to type-2 diabetes (a-glucosidase and a-amylase)
by Khaya senegalensis
This study evaluated the in vitro antioxidative activity of 
Khaya senegalensis extracts and inhibitory effects of some 
sol vent fractions on a-glucosidase and a-amylase activi-
ties. The stem bark, root and leaf samples of the plant were 
sequentially extracted with ethyl acetate, ethanol and wa-
ter and then tested for antioxidative activity. Our findings 
revealed that the ethanolic extract of the root had the high-
est antioxidative activity. Solvent-solvent fractionation of 
the root ethanolic extract yielded a butanol fraction that 
show ed higher antioxidative activity than other fractions. 
Furthermore, the butanol fraction had significantly higher 
(p < 0.05) a-glucosidase and a-amylase inhibitory activities 
with IC50 values of 2.89 ± 0.46 and 97.51 ± 5.72 µg mL–1, respec-
tively. Enzyme kinetic studies indicated that the butanol 
fraction is a non-competitive inhibitor for a-glucosidase with 
an inhibition binding constant Ki of 1.30 µg mL–1 and a com-
petitive inhibitor of a-amylase with a Ki of 7.50 µg mL–1. 
GC-MS analysis revealed that the butanol fraction con-
tained two chromones, p-anilinophenol and 3-ethyl-5-(3-
ethyl-(3H)-benzothiazol-2-ylidene)-2-(p-tolylvinylamino)-
4-thiazolidinone. Data obtained in the study suggest that 
the butanol fraction derived from the ethanolic extract of K. 
senegalensis root possessed excellent antioxidative as well 
as a-glucosidase and a-amylase inhibitory activities while 
chromones and/or p-anilinophenol could be the main bio-
active compounds responsible for the observed activities.
Keywords: Khaya senegalensis (Meliaceae), type-2 diabetes, 
a-glu co sidase, a-amylase, oxidative stress
Diabetes mellitus is among the major global public health problems and its prevalence 
is currently increasing at an alarming rate. According to the International Diabetes Fede-
ration, about 366 million people are living with diabetes and this figure is projected to 
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2 diabetes (T2D) is most prevalent and accounts for > 95 % of the total diabetic population 
worldwide. Type-2 diabetes is a heterogeneous disorder characterized by a progressive 
dec line in insulin action (insulin resistance), followed by the inability of pancreatic b-cells 
to compensate for insulin resistance (b-cell dysfunction) leading to hyperglycemia (2) while 
oxidative stress is a major contributor to the b-cell damage (3).
Oxidative stress refers to the existence of products called free radicals (molecules pos-
sessing an unpaired electron) and reactive oxygen species (ROS), which are formed in 
normal physiological processes but become deleterious when they are not quenched by a 
cascade of antioxidant systems. This can result either from an overproduction of ROS or 
from the inactivation of the antioxidants (AO), thereby shifting the ROS/AO balance in 
favor of stress (4). In T2D, hyperglycemia induces generation of free radicals, including 
ROS, hydroxyl and nitric oxide (NO) radicals (5), which are responsible for oxidative stress 
induced pancreatic b-cell destruction as well as the activation of all major pathways un-
derlying the different components of chronic vascular diabetic complications such as gly-
cation and sorbitol pathways among others (4). The concept of oxidative stress as an impor-
tant trigger, and postprandial hyperglycemia at the onset and progression of diabetes, 
offer a unique therapeutic strategy for the treatment of T2D and for reducing chronic vas-
cular complications (6). Current therapeutic strategy for the control of postprandial hyper-
glycemia is the inhibition of two members of exo-acting glycoside hydrolases (a-glucosi-
dase and a-amylase), resulting in an aggressive delay of carbohydrate digestion to 
absorbable monosaccharides (7). Starch and other complex polysaccharides are hydro-
lyzed by a-amylase to oligosaccharides, which are further hydrolyzed to liberate glucose 
by intestinal a-glucosidase before being absorbed into the intestinal epithelium and enter-
ing blood circulation. Therefore, a-glucosidase and a-amylase inhibitors will ultimately 
re duce the flow of glucose from complex dietary carbohydrates into the bloodstream, di-
minishing the postprandial hyperglycemia.
However, the leading glucosidase inhibitors, acarbose and miglitol, are often reported 
to produce diarrhea and other intestinal disturbances, with the corresponding bloating, 
flatulence, cramping and abdominal pain (8). Randomized controlled trials with glucosi-
dase inhibitors report these gastrointestinal side effects as the most common reasons for 
non-compliance and early subject withdrawal (9). Interestingly, plant based agents were 
reported to be more acceptable source of glucosidase inhibitors due to their low cost and 
relatively better safety levels, including lower incidence of serious gastrointestinal side 
effects (10). The foregoing therefore makes the search for alternative agents with potent 
antioxidative properties that could also decrease postprandial hyperglycemia, thereby 
providing a holistic avenue to control hyperglycemia and other diabetic complications 
resulting from oxidative stress, of the utmost importance.
Khaya senegalensis (Desr.) A. Juss. also known as African mahogany, is a member of the 
Meliaceae family and is highly reputed for its numerous medicinal effects. Ethnopharma-
cological surveys have revealed that the stem bark, root and leaves of the plant are used in 
the traditional treatment of diabetes, malaria, anemia, diarrhea, gastrointestinal diseases 
and fever amongst others (11, 12). Scientific investigations have revealed the anti-hypergly-
cemic activity of the aqueous stem bark extract of this plant in a type-1 diabetes model of 
rats (13) as well as an in vitro a-amylase inhibitory potential (14). However, detailed inves-
tigation of the complete antioxidative and a-glucosidase or a-amylase inhibitory activity 
of the extracts from different parts of this plant has not been conducted to date.
313
M. A. Ibrahim et al.: Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase)
by Khaya senegalensis, Acta Pharm. 64 (2014) 311–324.
 
Hence, in this study, we conducted a comprehensive and systematic investigation of 
the in vitro antioxidative as well as a-glucosidase and a-amylase inhibitory activities of 
various extracts and solvent fractions of K. senegalensis using complementary in vitro mod-
els, along with identification of active compounds in the most active fraction as well as 
establishing the mechanisms of a-glucosidase and a-amylase inhibitions by the most ac-
tive fraction via the enzyme kinetics approach.
EXPERIMENTAL
Chemicals and reagents
Yeast a-glucosidase, porcine pancreatic amylase, p-nitrophenyl-a-D-glucopyranoside 
(pNPG), p-nitrophenol, acarbose, gallic acid, 1,1-diphenyl-2-picrylhydrazyl radical (DPPH), 
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), 2-deoxy-D-ribose, ascor-
bic acid and potassium ferricyanide were obtained from Sigma-Aldrich, Germany. Starch, 
dinitrosalicylic acid (DNS), maltose, absolute ethanol, ethyl acetate, trichloroacetic acid, 
hydrogen peroxide, ferric chloride, Griess reagent, sodium nitroprusside, dimethylsulfox-
ide (DMSO), thiobarbituric acid and Folin Ciocalteau reagent were obtained from Merck 
Chemical Company, Germany.
Plant material
The stem bark, root and leaf samples of K. senegalensis (Meliaceae) were collected in 
January 2011 from the Botanical garden of the Department of Biological Sciences, Ahmadu 
Bello University Zaria, Nigeria, and the species was identified at the herbarium unit of the 
same department; herbarium voucher specimen was deposited. The stem bark, root and 
leaves were immediately washed and shade-dried for four weeks to constant mass. The 
dried samples were pounded to fine powder using a kitchen blender and then stored indi-
vidually in air-tight containers for subsequent analyses.
Preparation of crude extracts and solvent partitioning of the crude extract
Forty grams of a fine powdered sample from each part of the plant were separately 
defatted with hexane. Defatted materials were sequentially extracted with ethyl acetate, 
ethanol and water by soaking for 48 h in 200 mL of the relevant solvent, followed by shaking 
for 2 hours at 200 rpm. After filtration through Whatmann filter paper No. 1, the respec tive 
solvent was evaporated in vacuum using a rotary evaporator (Büchi Rotavapor II, Büchi, 
Switzerland) at 40 °C under reduced pressure. Aqueous extracts were however dried on a 
water bath at 50 °C. Based on the results of the antioxidative assays (described below), the 
most active ethanolic extract of the root was further fractionated. Ten grams of the crude 
ethanolic extract of the root was dissolved in 200 mL of distilled water/methanol (9:1) and 
successively partitioned with dichloromethane (2 x 200 mL), ethyl acetate (2 x 200 mL) and 
n-butanol (2 x 200 mL). The resulting fractions were evaporated to dryness at 40 °C under 
reduced pressure while the remaining aqueous fraction was dried on a water bath. The 
crude extracts and fractions in each case were weighed, transferred to micro tubes and 
stored at 4 °C until further analysis.
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Estimation of total phenolic content
The total phenolic content of each extract or fraction was determined (as gallic acid 
equivalent) according to the method described by McDonald et al. (15) with slight modifica-
tions. Briefly, 200 µL of the extract or fraction dissolved in 10 % DMSO (240 µg mL–1) was 
incubated with 1 mL of Folin Ciocalteau reagent (diluted 10 times) and 800 µL of 0.7 mol 
L–1 Na2CO3 for 30 min at room temperature. Then, the absorbance was measured at 765 nm 
on a Shimadzu UV mini 1240 spectrophotometer (Shimadzu, Japan). All measurements 
were done in triplicate.
DPPH radical scavenging activity
The total free radical scavenging activity of the tested extracts and fractions was de-
termined and compared to that of ascorbic and gallic acids as well as Trolox using a slight-
ly modified method described by Tuba and Gulcin (16). A 0.3 mmol L–1 solution of DPPH 
was prepared in methanol and 500 µL of this solution was added to 1 mL of the extract or 
fraction (dissolved in 10 % DMSO) at different concentrations (15–240 µg mL–1). These solu-
tions were mixed and incubated in the dark for 30 min at room temperature. Absorbance 
was then measured at 517 nm against a blank samples lacking scavenger.
Hydroxyl radical scavenging (HRS) activity (deoxyribose assay)
The HRS activity was measured by studying the competition between deoxyribose 
and the extracts or fractions for hydroxyl radical generated by the ascorbate/EDTA/H2O2 
system (Fenton reaction) as described by Hinnerburg et al. (17). The assay was performed 
by adding 200 µL of premixed 100 µmol L–1 FeCl3 and 100 µmol L–1 EDTA (1:1, V/V) solu-
tion, 100 µL of 10 mmol L–1 H2O2, 360 µL of 10 mmol L–1 2-deoxy-D-ribose, 1 mL of different 
extracts or fractions dissolved in 10 % DMSO (concentration 15–240 µg mL–1), 400 µL of 50 
mmol L–1 sodium phosphate buffer (pH 7.4) and 100 µL of 1 mmol L–1 ascorbic acid as per 
the above-mentioned sequence. The mixture was incubated at 50 °C for 2 h. Thereafter, 1 
mL of 2.8 % TCA and 1 mL of 1.0 % thiobarbituric acid (in 0.025 mmol L–1 NaOH) were 
added to each tube. The samples were further incubated in a water bath at 50 °C for 30 min 
to develop the pink chromogen. The extent of oxidation was estimated from the absor-
bance of the solution at 532 nm and the HRS activity of the extract is reported as percentage 
inhibition of deoxyribose degradation.
Nitric oxide (NO) radical scavenging assay
Sodium nitroprusside in aqueous solution at physiological pH spontaneously gene-
rates NO, which interacts with oxygen to produce nitrite ions, which can be estimated by 
the use of Griess reagent. Scavengers of NO compete with oxygen, leading to reduced 
production of NO (18). The assay was carried out by incubating 500 µL of 10 mmol L–1 so-
dium nitroprusside in phosphate buffer (pH 7.4) and 500 µL of different extracts or frac-
tions dissolved in 10 % DMSO (concentration 15–240 µg mL–1) at 37 °C for 2 h. The reaction 
mixture was then mixed with 500 µL of Griess reagent. The absorbance of the chromo-
phore formed during the diazotization of nitrite with sulphanilamide and subsequent 
coupling with napthylethylenediamine was read at 546 nm. The percentage inhibition of 
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NO generated was measured in comparison with the absorbance value of a control (10 
mmol L–1 sodium nitroprusside in phosphate buffer).
Determination of a-glucosidase inhibitory activity of fractions of the root ethanolic 
extract
The a-glucosidase inhibitory activity was determined according to the method de-
scribed by Ademiluyi and Oboh (6), with slight modifications. Briefly, 250 µL of each frac-
tion or acarbose, at different concentrations (30–240 µg mL–1), was incubated with 500 µL 
of 1.0 U mL–1 a-glucosidase solution in 100 mmol L–1 phosphate buffer (pH 6.8) at 37 °C for 
15 min. Thereafter, 250 µL of pNPG solution (5 mmol L–1) in 100 mmol L–1 phosphate buffer 
(pH 6.8) was added and the mixture was further incubated at 37 °C for 20 min. The absor-
bance of the released p-nitrophenol was measured at 405 nm and the inhibitory activity 
was expressed as percentage of a control sample without inhibitors.
Determination of a-amylase inhibitory activity of fractions of the root ethanolic extract
The a-amylase inhibitory activity was determined according to the method described 
by Shai et al. (19), with slight modifications. A volume of 250 µL of each fraction dissolved 
in 10 % DMSO or acarbose at different concentrations (30–240 µg mL–1) was incubated with 
500 µL of porcine pancreatic amylase (2 U mL–1) in 100 mmol L–1 phosphate buffer (pH 6.8) 
at 37 °C for 20 min. Two hundred and fifty µL of 1 % starch dissolved in 100 mmol L–1 
phosphate buffer (pH 6.8) was then added to the reaction mixture and incubated at 37 °C 
for 1 h. One mL of DNS color reagent was then added and boiled for 10 min. The absor-
bance of the resulting mixture was measured at 540 nm and the inhibitory activity was 
expressed as percentage of a control sample without inhibitors. All assays were carried out 
in triplicate.
Mechanism of a-glucosidase and a-amylase inhibitions
The most active (butanol) fraction was subjected to kinetic experiments to determine 
the type of inhibition exerted on a-glucosidase and a-amylase. The experiment was con-
ducted according to the protocols as described above at a constant concentration of sample 
fraction (30 µg mL–1) with a variable concentration of substrate. For the a-glucosidase in-
hibition assay, 0.625–5 mmol L–1 of pNPG was used and 0.125–1 % of starch was used for 
the a-amylase inhibition assay. The initial rates of reactions were determined from calibra-
tion curves constructed using varying concentrations of p-nitrophenol and maltose for the 
a-glucosidase and a-amylase inhibition assays, respectively. The initial velocity data ob-
tained were used to construct Lineweaver-Burke’s plot to determine the KM (Michaelis 
constant) and vmax (maximum velocity) of the enzyme as well as the Ki (inhibition binding 
constant as a measure of affinity of the inhibitor to the enzyme) and the type of inhibition 
for both enzymes.
Gas chromatography-mass spectrometric (GC-MS) analysis
The most active (butanol) fraction was further subjected to GC-MS analysis. The anal-
ysis was conducted with an Agilent Technologies 6890 GC coupled with an Agilent 5973 
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mass selective detector and driven by Agilent Chemstation software (Agilent Technolo-
gies, USA). A DB-5SIL MS capillary column was used (30 m x 0.25 mm i.d., x 0.25 µm film 
thickness). The carrier gas was ultra-pure helium at a flow rate of 0.7 mL min–1 and a linear 
velocity of 37 cm s–1. The injector temperature was set at 250 °C. The initial oven tempera-
ture was 60 °C, which was programmed to 280 °C at the rate of 10 °C min-1 with a hold time 
of 3 min. Injections of 2 µL were made in the splitless mode with a manual split ratio of 
20:1. The mass spectrometer was operated in the electron ionization mode at 70 eV and 
electron multiplier voltage at 1859 V. Other MS operating parameters were as follows: ion 
source temperature 230 °C, quadrupole temperature 150 °C, solvent delay 4 min and scan 
range 50-700 amu. Compounds were identified by direct comparison of the retention times 
and mass fragmentation pattern with those from the National Institute of Standards and 
Technology (NIST) library.
Statistical analysis
Data were analyzed using a statistical software package (SPSS for Windows, version 
18, IBM Corporation, USA) using Tukey’s-HSD multiple range post-hoc test. Values were 
considered significantly different at p < 0.05.
RESULTS AND DISCUSSION
The present study revealed that the butanol fraction of ethanolic extract of the root of 
K. senegalensis contained powerful antioxidative agents as well as inhibitors of a-gluco si-
dase and a-amylase.
Ethanolic extracts were found to contain significantly (p < 0.05) higher amounts of total 
phenolics than other extracts, with the highest amount being present in the ethanolic ex-
tract of the stem bark 107.31 ± 3.05 mg g–1 GAE (Table I). The antioxidative activities (using 
DPPH, HRS and NO models) of the extracts from the different parts of K. senegalensis are 
summarized in Table II. All the extracts from the plant scavenged DPPH radicals; how-
ever, the ethanolic extracts of the stem bark and root as well as the aqueous extract of the 
leaves displayed a statistically similar but significantly (p < 0.05) higher DPPH radical scav-
enging activity than all other extracts from the plant. Further, all the extracts could scav-
enge hydroxyl radicals generated by Fenton’s reaction except the ethyl acetate extracts of 
the stem bark and leaves, which showed pro-oxidative tendencies in this model. The ethyl 
acetate extract of the root showed the best HRS activity with an IC50 value of 1.68 ± 0.27 µg 
mL–1, followed by the ethanolic extracts from all the parts of the plant, which had higher 
HRS activity than the standard antioxidant Trolox. The highest NO scavenging activity 
was observed with the ethanolic extract of the leaves (IC50 value of 6.92 ± 1.42 µg mL–1) fol-
lowed by the stem bark aqueous extract and ethanolic extract of the root, which had a 
statistically similar NO scavenging activity to that of ascorbic acid. Three experimental 
models for in vitro antioxidative studies were used because a single model cannot provide 
a full evaluation of the antioxidative capabilities of the different extracts tested due to the 
involvement of multiple mechanisms. Interestingly, analysis of the results obtained from 
the three complementary models for antioxidative studies revealed that the ethanolic ex-
tract of the root contained active constituents which could reasonably scavenge all the 
various forms of the reactive species tested. This further suggests that the components of 
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this plant with high redox potentials are ethanol extractable. Guided by these activities, 
solvent fractionation of the ethanolic extract of the root was carried out.
Using solvent-solvent fractionation, the ethanolic extract of the root was fractionated 
to obtain a dichloromethane, ethyl acetate, butanol and aqueous fraction. The butanol frac-
tion had a significantly (p < 0.05) higher DPPH radical scavenging activity (IC50 value of 
3.11 ± 0.77 µg mL–1) than the other fractions (Table III). However, the ethyl acetate and di-
chloromethane fractions had significantly higher (p < 0.05) hydroxyl and NO radical scav-
enging activities than the other fractions (Table III). However, the overall results suggested 
that the butanol fraction possessed better antioxidant and scavenging activities than the 
other fractions because its antioxidant activity cuts across the experimental models used. 
This is indicative of the presence of powerful compounds that might have the ability to 
inhibit free radical upsurge as well as oxidative stress. These compounds, either in pure 
form or in combination, could be useful therapeutic agents for treating oxidative stress 
based metabolic disorders.
Fig. 1 shows the inhibition of a-glucosidase and a-amylase by fractions of the ethano-
lic extract of the root. All the fractions inhibited a-glucosidase and a-amylase activities in 
vitro in a dose dependent pattern. The more polar (aqueous and butanol) fractions consis-
tently maintained higher inhibitory activities against the enzymes than the less polar 
(ethyl acetate and dichloromethane) fractions. Furthermore, as shown by the IC50 values, 
the butanol fraction had a significantly (p < 0.05) higher inhibitory activity than other frac-
Table I. Percentage yield and total polyphenol content of fractions of K. senegalensis parts
Sample Yield (%) Total polyphenols (mg g–1 GAE)
Stem bark
Ethyl acetate 1.4 50.62 ± 0.08c
Ethanolic 4.8 107.31 ± 3.05g
Aqueous 3.5 59.64 ± 1.03d
Root
Ethyl acetate 1.0 13.70 ± 0.37b
Ethanolic 2.9 97.76 ± 0.66f
Aqueous 2.6 58.32 ± 1.76d
Leaves
Ethyl acetate 1.4 12.08 ± 0.12a
Ethanolic 3.0 77.38 ± 1.27e
Aqueous 3.8 14.08 ± 0.74b
GAE – gallic acid equivalents. Data are presented as mean ± SD values of triplicate determinations.
a-g  Different letters stand for significantly different values from each other within a column (Tukey’s-HSD 
multiple range post hoc test, p < 0.05); the same letters stand for non-significant difference.
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Ethyl acetate    7.15 ± 2.12c P  3205.41 ± 760.44h
Ethanol    1.99 ± 0.87a  2.08 ± 0.28a 63.75 ± 4.81c
Aqueous 195.01 ± 45.60f 15.13 ± 1.25d 28.50 ± 7.71b
Root
Ethyl acetate 48.20 ± 3.47e  1.68 ± 0.27a  95.32 ± 6.08d
Ethanol    1.59 ± 0.64a  2.18 ± 0.45a  29.23 ± 1.87b
Aqueous 22.71 ± 3.47d 4.85 ± 0.61c 192.70 ± 33.91e
Leaves
Ethyl acetate 44.67 ± 4.62e P  47.75 ± 5.92c
Ethanol    3.25 ± 0.57b  2.44 ± 0.53a    6.92 ± 1.42a
Aqueous    1.40 ± 0.22a   59.31 ± 12.43e 183.45 ± 15.18e 
Ascorbic acid      2.56 ± 0.26ab ND  26.40 ± 6.46b
Gallic acid    1.40 ± 0.43a ND 1053.48 ± 239.92g
Trolox    8.47 ± 2.88c    3.23 ± 0.49ab  629.76 ± 63.98f
DPPH – 1,1-diphenyl-2-picrylhydrazyl radical, HRS – hydroxyl radical scavenging, NO – nitric oxide radical
P – extract showed pro-oxidative properties in the experimental model.
ND – not determined. Data are presented as mean ± SD values of triplicate determinations.
a-g  Different letters stand for significantly different values from each other within a column 
(Tukey’s-HSD multiple range post hoc test, p < 0.05); the same letters stand for non-significant difference.
tions with IC50 values of 2.89 ± 0.46 and 97.51 ± 5.72 µg mL–1 for a-glucosidase and a-amy-
lase inhibition, respectively (Table IV). Thus, the strong inhibition of a-glucosidase by the 
butanol fraction would slow down the breakdown of disaccharides to liberate glucose, 
thereby reducing glucose absorption from the small intestine (20). Furthermore, in spite of 
abundant reports on the a-glucosidase inhibitory activities of extracts and pure com-
pounds from plants from different parts of the world, only a few authors (21) reported such 
a low IC50 value as found with the butanol fraction in our study. This observation might 
be connected to the high phenolic content recorded in this fraction, because polyphenolic 
fractions from plants have been shown to inhibit a-glucosidase activity, allowing for tight-
er control of blood glucose (22). Furthermore, Mai et al. (23) reported a strong positive cor-
relation between the polyphenolic content and a-glucosidase inhibitory effects of 28 ex-
tracts from Vietnamese edible plants, but also suggested that the enzymatic inhibition 
might depend on the type of polyphenolic. In the same vein, the butanol fraction had the 
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Fig. 1. a) a-glucosidase and b) a-amylase inhibitory activities of different solvent fractions of ethano-
lic extract of the K. senegalensis root. Data are presented as mean ± SD of triplicate determinations.
a-d Different letters over the bars for a given concentration for each extract indicate a significant dif-
ference from each other (Tukey’s-HSD multiple range post hoc test, p < 0.05).
Table III. IC50 values of various fractions of the ethanolic extract of K. senegalensis root in different 
antioxidative models
Fraction Total phenolics (mg g–1 GAE)
IC50 (µg mL–1) IC50 (mg mL–1)
DPPH HRS NO 
Aqueous 128.23 ± 1.73b 27.71 ± 0.87b 62.45 ± 0.72c   6.92 ± 0.4c
Butanol 201.24 ± 4.64d   3.11 ± 0.77a 41.20 ± 2.27b 35.89 ± 3.24d
Ethyl acetate 182.15 ± 2.78c   3.78 ± 1.12a 31.53 ± 4.22a   3.58 ± 0.5b
Dichloromethane     7.71 ± 3.30a 91.00 ± 1.09c 58.31 ± 4.74c  104.84 ± 0.04a
DPPH – 1,1-diphenyl-2-picrylhydrazyl radical, HRS – hydroxyl radical scavenging, NO – nitric oxide radical.
Data are presented as mean ± SD values of triplicate determinations.
a-d  Different letters stand for significantly different values from each other within a column 
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Table IV. IC50 values for the inhibition of a-glucosidase and a-amylase by various solvent fractions of the 




Aqueous   5.15 ± 1.10b 130.23 ± 12.90b
Butanol   2.89 ± 0.46a    97.51 ± 5.72a
Ethyl acetate 23.89 ± 0.70c 394.97 ± 13.46d
Dichloromethane 91.23 ± 2.17e 154.64 ± 6.67e*
Acarbose 55.59 ± 5.22d 256.66 ± 20.52c
Data are presented as mean ± SD of triplicate determinations.
a-e  Different letters stand for significantly different values from each other within a column 
(Tukey’s-HSD multiple range post hoc test, p < 0.05); the same letters stand for non-significant difference.
*  IC50 in mg/mL–1.
Table V. Identified components of the butanol fraction of the K. senegalensis root ethanolic extract by GC-MS
Peak No. Compound tR (min) Mr
1 7,8-dihydroxy-2,3-dihydrochromone 9.35 181.05
2 5,7-dihydroxychromone 12.53 179.03
3 p-anilinophenol hydrochloride 16.49 221.06
4 3-ethyl-5-(3-ethyl-(3H)-benzothiazol-2-ylidene)-2-(p-tolylvinylamino)-4-thiazolidinone 22.76 423.14
highest a-amylase inhibitory activity, which suggests the presence of more active com-
pounds that could inhibit the breakdown of complex carbohydrates to oligosaccharides, 
thereby diminishing the effect of carbohydrate consumption on postprandial hyperglyce-
mia. Moreover, the observed higher a-glucosidase inhibitory activity of the butanol frac-
tion than the corresponding a-amylase activity is of great pharmaceutical interest. This is 
because some of the side effects associated with the currently available drugs for the man-
agement of T2D are linked with excessive inhibition of a-amylase activity (6).
The enzyme kinetic studies revealed that the butanol fraction is a non-competitive 
inhibitor of a-glucosidase with vmax decreasing from 655.09 to 27.38 µmol min–1. The KM 
remained unchanged at 2.00 mmol L–1 and the computed Ki value for inhibiting a-gluco-
sidase was 1.30 µg mL–1 (Fig. 2a). This observation could indicate that the fraction bound 
the a-glucosidase at separate site(s) of the enzyme (rather than the active site) but caused 
conformational modification at the active site, thereby preventing effective binding of the 
pNPG and consequently reducing the a-glucosidase activity. It further suggests that the 
fraction contains some components capable of interacting with the a-glucosidase-pNPG 
complex (24). Conversely, the mechanism of inhibition of a-amylase by the butanol fraction 
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Fig. 2. Lineweaver-Burke’s plot of a) a-glucosidase and b) a-amylase catalyzed reactions in the pres-
ence and in the absence of the butanol fraction derived from the K. senegalensis root ethanolic extract.
Fig. 3. GC-MS chromatogram of the butanol fraction of the K. senegalensis root ethanolic extract.
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Fig. 4. Structures of components identified by GC-MS.
revealed a competitive inhibition pattern with a KM value of 1.25 and 0.25 % in the pres-
ence and absence of the inhibitor, respectively. The vmax of the a-amylase was not affected 
(33.70 µmol min–1) and Ki for inhibiting a-amylase by the fraction was 7.50 µg mL–1 (Fig. 
2b). Thus, this pattern of a-amylase inhibition by the fraction suggests that the active site 
of the enzyme is directly involved in the inhibitory action and the fraction most likely 
contains some compounds that could serve as substrate analogues, thereby competing for 
the active site of a-amylase (25).
The GC-MS chromatogram of the butanol fraction is presented in Fig. 3. The major 
peaks detected in the chromatogram of the butanol fraction were those of the chromones 
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7,8-dihydroxy-2,3-dihydrochromone (peak 1), 5,7-dihydroxychromone (peak 2), p-ani-
linophenol hydrochloride (peak 3) and 3-ethyl-5-(3-ethyl-(3H)-benzothiazol-2-ylidene)-2-
(p-tolylvinylamino)-4-thiazolidinone (peak 4). They were identified by their fragmentation 
pattern and in conjunction with the NIST library (Fig. 4). The retention time and molecular 
mass of the detected components are provided in Table V. Phenolics are very important 
constituents among the secondary metabolites of plants because of their multiple biologi-
cal effects and direct contribution to antioxidative and a-glucosidase inhibitory activities 
(23). While not discounting the possible contributions of the other detected phytochemi-
cals, it is possible to suggest that the bioactive agents of the butanol fraction contain phe-
nolic groups such as those present in the two chromones 7,8-dihydroxy-2,3-dihydrochrom-
one and 5,7-dihydroxychromone identified by GC-MS.
CONCLUSIONS
The results of this study suggests that the butanol fraction derived from the ethanolic 
extract of K. senegalensis root contains the most potent a-glucosidase and a-amylase in-
hibitory agents and that the inhibitions were mediated via non-competitive and competi-
tive patterns for a-glucosidase and a-amylase, respectively. Further, the chromones and/
or p-anilinophenol could be bioactive agents and hence they can be investigated as novel 
anti-diabetic therapeutics.
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